<div id="readability-page-1"><p><span>Stryker (NYSE:SYK - Get Free Report)</span> had its price target cut by stock analysts at Truist Financial  from $400.00 to $392.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a &#34;hold&#34; rating on the medical technology company's stock. Truist Financial's target price suggests a potential upside of 8.98% from the stock's current price.</p><ul><li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li></ul><p>Several other equities research analysts have also recently commented on SYK. Rothschild &amp; Co Redburn assumed coverage on Stryker in a report on Thursday, September 18th. They set a &#34;neutral&#34; rating and a $420.00 target price on the stock. Redburn Partners  set a $420.00 price target on Stryker in a research report on Thursday, September 18th. UBS Group  set a $408.00 price target on Stryker in a research note on Monday, October 13th. Evercore ISI reduced their price objective on shares of Stryker from $410.00 to $405.00 and set an &#34;outperform&#34; rating for the company in a research note on Friday, October 31st. Finally, Wall Street Zen cut shares of Stryker from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, December 13th. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned  a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $431.39.</p><p><b>Get Our Latest Report on Stryker</b></p><h2>Stryker Stock Performance</h2><ul><li>Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?</li></ul><p>Shares of SYK traded up $7.13 during trading hours on Thursday, reaching $359.71. 381,748 shares of the company's stock traded hands, compared to its average volume of 1,457,759. Stryker has a twelve month low of $329.16 and a twelve month high of $406.19. The business's fifty day simple moving average is $365.79 and its two-hundred day simple moving average is $377.86. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. The firm has a market capitalization of $137.56 billion, a price-to-earnings ratio of 47.22, a P/E/G ratio of 2.49 and a beta of 0.89. </p><p>Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $3.13 by $0.06. The business had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The company's quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.87 earnings per share. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS.  Analysts predict that  Stryker will post 13.47 earnings per share for the current year. </p><h2>Insider Transactions at Stryker</h2><ul><li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li></ul><p>In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of the business's stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the completion of the sale, the director owned 2,702,108 shares of the company's stock, valued at $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, CFO Preston Wendell Wells sold 165 shares of the stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the transaction, the chief financial officer owned 6,694 shares in the company, valued at approximately $2,449,200.72. This trade represents a 2.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 522,118 shares of company stock worth $185,381,932 in the last 90 days. 5.90% of the stock is owned by insiders. </p><h2>Institutional Inflows and Outflows</h2><p>A number of hedge funds and other institutional investors have recently bought and sold shares of SYK. Two Point Capital Management Inc. bought a new stake in  Stryker during the second quarter worth about $7,281,000.  Alecta Tjanstepension Omsesidigt lifted its position in  Stryker by 82.0% during the 2nd quarter. Alecta Tjanstepension Omsesidigt now owns 458,300 shares of the medical technology company's stock worth $181,235,000 after buying an additional 206,500 shares in the last quarter.  SVB Wealth LLC bought a new stake in  Stryker during the 2nd quarter worth about $4,785,000.  AXQ Capital LP acquired a new stake in shares of  Stryker in the second quarter valued at approximately $567,000.  Finally, United Services Automobile Association acquired a new stake in shares of  Stryker in the 1st quarter valued at $2,857,000. 77.09% of the stock is currently owned by institutional investors and hedge funds. </p><h2>About Stryker</h2> (Get Free Report)<p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Stryker</li><li>What is the Hang Seng index?  </li><li>Micron’s Q1 Results Say “AI Bubble Is Far From Bursting”</li><li>What is a Stock Market Index and How Do You Use Them?</li><li>3 Cheap Dividend Stocks That Can Beat Inflation and Pay You to Wait</li><li>When to Sell a Stock for Profit or Loss</li><li>3 New Year’s Resolution Stocks That Could Turn Around in 2026</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Stryker Right Now?</h2><p>Before you consider Stryker, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Truist Financial lowered Stryker's target price from $400 to $392, maintaining a "hold" rating. Analysts have varied opinions, with target prices ranging from $405 to $420. Stryker's stock has a consensus "Moderate Buy" rating and an average target price of $431.39. Recent insider sales and institutional transactions are noted, with insiders selling 522,118 shares worth $185 million in the last 90 days.</p>

Truist Financial Has Lowered Expectations for Stryker (NYSE:SYK) Stock Price